To view this email as a web page, click here.
 
HIGHLIGHTS   |  May 23, 2019
 
The Promise of Liquid Biopsies in the Management of Lung Cancer
Cancer Network spoke with Dr. Bob Li and Dr. Donald Johann about the use of liquid biopsies in the management of lung cancer.
Read more
 
Adding the T-Cell Booster Decitabine to Anti–PD-1 Therapy in Hodgkin Lymphoma
Researchers tested the addition of the T cell–boosting decitabine to anti–PD-1 therapy with camrelizumab among patients with relapsed or refractory classic Hodgkin lymphoma.
Read more
ADVERTISEMENT
Advertisement
 
IN CASE YOU MISSED IT
 
De-Escalating Treatment in Metastatic HER2+ Breast Cancer: Is it Safe?
Researchers tested omitting chemotherapy from a treatment regimen involving dual blockade with pertuzumab and trastuzumab in patients with metastatic HER2+ breast cancer.
Read more
 

This is a post-only, outbound email. Please do not reply to this email as we will be unable to respond to your reply. Please use the links provided if you have questions or concerns regarding this email or your subscription.